Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 641

Results For "GE"

8409 News Found

Jonathan Peacock elected Chairman of the Board of Directors of Avantor
People | May 13, 2022

Jonathan Peacock elected Chairman of the Board of Directors of Avantor

Peacock also serves as a Director and Chair of the Audit and Finance Committee of UCB SA, a biopharmaceutical company focusing on neurology and immunology


All India Institute of Ayurveda (AIIA) celebrates Nurses Awareness Week
News | May 13, 2022

All India Institute of Ayurveda (AIIA) celebrates Nurses Awareness Week

As part of the celebrations, the Institute organised a series of activities in the run up to International Nurses Day which is observed on 12th May every year


The focus in FY 23 for most players would be international markets and ROW exports: Ankit Poddar, director, Candle Partners
interviews | May 12, 2022

The focus in FY 23 for most players would be international markets and ROW exports: Ankit Poddar, director, Candle Partners

Candle Partners, an investment banking & advisory service for M&A among others, has closed many deals in the healthcare space. Ankit Poddar, Director, Candle Partners spoke to Thomas C Thottathil, Editor, Indianpharmapost.com about the prospects for the industry.


Philips expands manufacturing and research facility in Pune, Maharashtra
News | May 12, 2022

Philips expands manufacturing and research facility in Pune, Maharashtra

The company exports mobile surgery equipment to over 100 countries from Pune


Mawi DNA Technologies launches NextSWAB for Covid-19 test results
Biotech | May 12, 2022

Mawi DNA Technologies launches NextSWAB for Covid-19 test results

NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing


First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial
Biotech | May 12, 2022

First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial

CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng


USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19
Drug Approval | May 12, 2022

USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19

Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19


Suven Pharmaceuticals - CDMO core growth intact; formulations to pick up
News | May 12, 2022

Suven Pharmaceuticals - CDMO core growth intact; formulations to pick up

Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins


‘One Step’ portal to provide information on medical tourism: Dr Mansukh Mandaviya
News | May 12, 2022

‘One Step’ portal to provide information on medical tourism: Dr Mansukh Mandaviya

“We are committed to making India a global medical value hub by further strengthening our traditional medicine industry and boosting 'Heal in India' & 'Heal by India'


Medikabazaar conducts successful trial of medical supplies through drone delivery
Startup | May 11, 2022

Medikabazaar conducts successful trial of medical supplies through drone delivery

The company intends to begin using drones to make deliveries of critical and emergency medical supplies, vaccines, and lifesaving drugs after getting the prerequisite regulatory approvals